CSL vs FMG
Side-by-side comparison of CSL Ltd and Fortescue Ltd — key metrics, sector exposure, and performance analysis.
Health Care
CSLCSL Ltd
A$138.93
-43.8% 1Y
CSL is a global biotechnology leader focused on plasma-derived therapies, vaccines, and specialty biologics.
Materials
FMGFortescue Ltd
A$20.25
31.6% 1Y
Fortescue is a leading iron ore producer with a growing focus on green energy and decarbonisation.
Head-to-Head Comparison
| Metric | CSL | FMG |
|---|---|---|
| Share Price | A$138.93 | A$20.25 |
| Market Cap | A$69.0B | A$64.9B |
| Daily Change | -2.28% | -3.98% |
| 1Y Performance | -43.8% | +31.6% |
| Volume | 1.02M | 6.54M |
| 52W High | A$275.79 | A$23.38 |
| 52W Low | A$133.35 | A$13.18 |
| P/E Ratio | 33.43 | 11.54 |
| Dividend Yield | 3.07% | 6.02% |
| EPS | A$4.1563 | A$1.7548 |
Summary
CSL (CSL Ltd) operates in the Health Care sector with a market capitalisation of A$69.0B. The stock has declined 43.8% over the past year.
FMG (Fortescue Ltd) operates in the Materials sector with a market capitalisation of A$64.9B. The stock has gained 31.6% over the past year.
These stocks span Health Care and Materials, offering investors a cross-sector comparison to assess diversification and risk balance.